Science Translational MedicineNeurosciencePeer-reviewed journal article
Genipin Crosslinks the Extracellular Matrix to Rescue Developmental and Degenerative Defects, and Accelerates Regeneration of Peripheral Neurons
Kenyi Saito‐DiaziD, Paula DietrichiD, Tripti SainiiD, Md. Mamunur RashidiD, Hsueh‐Fu WuiD, Mohamed IshaniD, Xin SuniD, Sydney BedillioniD, Archie Jayesh PateliD, Anthony Robert PruddeniD, Camryn WzientekiD, Trinity Nora KnightiD, Ya‐Wen CheniD, Geert‐Jan BoonsiD, Shuibing CheniD, Lorenz StuderiD, Michael TiemeyeriD, Bingqian XuiD, Ioannis DragatsisiD, Hong‐Xiang LiuiD, Nadja ZeltneriD
Abstract
The peripheral nervous system (PNS) is essential for proper body function. A high percentage of the population suffer nerve degeneration or peripheral damage. For example, over 40% of patients with diabetes or undergoing chemotherapy develop peripheral neuropathies. Despite this, there are major gaps in the knowledge of human PNS development and therefore, there are no available treatments. Familial Dysautonomia (FD) is a devastating disorder that specifically affects the PNS making it an ideal model to study PNS dysfunction. FD is caused by a homozygous point mutation in ELP1 leading to developmental and degenerative defects in the sensory and autonomic lineages. We previously employed human pluripotent stem cells (hPSCs) to show that peripheral sensory neurons (SNs) are not generated efficiently and degenerate over time in FD. Here, we conducted a chemical screen to identify compounds able to rescue this SN differentiation inefficiency. We identified that genipin, a compound prescribed in Traditional Chinese Medicine for neurodegenerative disorders, restores neural crest and SN development in FD, both in the hPSC model and in a FD mouse model. Additionally, genipin prevented FD neuronal degeneration, suggesting that it could be offered to patients suffering from PNS neurodegenerative disorders. We found that genipin crosslinks the extracellular matrix, increases the stiffness of the ECM, reorganizes the actin cytoskeleton, and promotes transcription of YAP-dependent genes. Finally, we show that genipin enhances axon regeneration in an in vitro axotomy model in healthy sensory and sympathetic neurons (part of the PNS) and in prefrontal cortical neurons (part of the central nervous system, CNS). Our results suggest genipin can be used as a promising drug candidate for treatment of neurodevelopmental and neurodegenerative diseases, and as a enhancer of neuronal regeneration. One sentence summaryGenipin rescues the developmental and degenerative phenotypes of the peripheral neuropathy familial dysautonomia and enhances neuron regeneration after injury.
- organism: human
- organism: mouse
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 14
- FWCI
- 2.45
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Muscle-resident mesenchymal progenitors sense and repair peripheral nerve injury via the GDNF-BDNF axis
Kyusang Yoo, Young‐Woo Jo, … Young‐Yun Kong·eLifePeer-reviewed·Aug 30, 2024
- Induced pluripotent stem cell-derived primary proprioceptive neurons as Friedreich ataxia cell model
Chiara Dionisi, Myriam Rai, … Massimo Pandolfo·bioRxiv·Nov 6, 2019
- The manipulation of spinal motor neuron axonal growth promotes spinal cord repair
- FoxP transcription factors are required for peripheral nervous system development
Hanna Yeliseyeva, Nikita Vladimirov, Esther T. Stoeckli·bioRxiv·Sep 24, 2026
- Fidgetin-like 2 is a novel negative regulator of axonal growth and can be targeted to promote functional nerve regeneration after injury.
Lisa M. Baker, Moses Tar, … David J. Sharp·bioRxiv·Mar 19, 2020
- Development of a novel oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia.
Elisabetta Morini, Anil K. Chekuri, … Susan Slaugenhaupt·The American Journal of Human GeneticsPeer-reviewed·Feb 20, 2023